MS40 40mg*10vials

MOTS-c MS40 40mg x 10 Vials

Product Overview

MOTS-c MS40 is a high-concentration formulation in the MOTS-c mitochondrial metabolic peptide series, representing an upgraded version surpassing the MS10, MS15, and MS20 specifications. As a highly active endogenous mitochondrial-encoded short-chain peptide, it exhibits zero immunogenicity and excellent biocompatibility, inheriting the unique exercise-mimicking metabolic activation mechanism of the MOTS-c series. The 40mg high-concentration dose exceeds the traditional 20mg dose saturation range, supporting research on AMPK energy pathway activation and mTOR pathological signal inhibition, metabolic remodeling, mitochondrial damage repair, and systemic anti-aging effects. It is designed for severe refractory metabolic disorder modeling and end-stage research, serving as an advanced preclinical research material for mitochondrial physiology, metabolic pharmacology, and degenerative aging research.

Core Research Functions

Exercise-Mimicking Metabolic Activation: Supports AMPK energy cascade activation research and metabolic inertia intervention studies.

Insulin Sensitivity Enhancement: Supports insulin sensitivity enhancement research and glucose metabolism disorder correction studies.

Lipid Accumulation Breakdown: Supports visceral, liver, and systemic lipid accumulation breakdown research.

Mitochondrial Oxidative Stress and Inflammation Modulation: Supports severe mitochondrial oxidative stress and chronic inflammation elimination research.

Senescent Cell Clearance: Supports senescent cell elimination and multi-organ degenerative aging process intervention research.

The efficacy of MS40 40mg exceeds the saturation level of MS20, supporting high-amplitude experimental phenotype generation, long-term stable efficacy output, and multi-organ physiological homeostasis reset research under full load conditions. It targets research on severe refractory metabolic syndrome, end-stage mitochondrial dysfunction, advanced deep tissue aging, and refractory low-grade inflammation accumulation that show limited response to conventional high-dose regimens. It supports research on metabolic failure intervention caused by high-fat diet, liver, visceral cavity, and peripheral tissue lipid deposit clearance, and systemic energy circulation efficiency and exercise physiological potential enhancement. It also supports multi-organ mitochondrial function repair, accumulated oxidative free radical elimination, persistent chronic inflammation intervention, and multi-organ protection and anti-aging effect research, providing high-precision, reproducible data for advanced mitochondrial metabolic anti-aging research.

Key Advantages

High-Concentration Mitochondrial Pathway Activation: The 40mg high-dose formulation supports AMPK pathway activation research through supersaturation, exceeding the saturation limit of traditional flagship formulations. It supports mitochondrial biosynthesis and energy conversion efficiency enhancement research, reaching the upper range of mitochondrial metabolic activation in the MOTS-c series.

Enhanced Metabolic Disorder Correction: Possesses high-intensity glucose and lipid remodeling and insulin resistance intervention capabilities, supporting end-stage refractory severe metabolic disorder correction research that exceeds MS20 saturation dose response ranges. This represents the advanced range of MOTS-c peptide metabolic regulatory efficacy.

Five-Dimensional System Physiological Reset: Integrates exercise-simulated fat burning, refractory hyperglycemia correction, systemic lipid clearance, mitochondrial oxidative stress modulation, and senescent cell elimination, providing comprehensive multi-dimensional metabolic and anti-aging research capabilities.

Mitochondrial Function and Energy Metabolism Support: Supports mitochondrial biosynthetic reconstruction research, mitochondrial function comprehensive repair in multiple organs, and systemic energy circulation efficiency enhancement under severe metabolic stress conditions.

High-Purity Process and Quality Control: Employs advanced multi-stage gradient deep purification and low-temperature vacuum lyophilization technology, preserving active peptide structure with minimal impurity content. Packaged as 10 vials per dust-free aseptic pack, fully tested for purity by HPLC, and accompanied by a complete Certificate of Analysis (COA), suitable for high-standard advanced laboratory research and premium bulk custom procurement.

Specifications and Quality Control

Format: Lyophilized powder, 40mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).